Heparin in the Prevention of Deep Vein Thrombosis after Myocardial InfarctionBr Med J 1972; 2 doi: https://doi.org/10.1136/bmj.2.5811.436 (Published 20 May 1972) Cite this as: Br Med J 1972;2:436
- Anthony J. Handley,
- Peter A. Emerson,
- P. R. Fleming
A trial of continuous intravenous heparin in the prevention of deep vein thrombosis was undertaken in 48 patients who had suffered a myocardial infarction. Of the 24 control patients who did not receive heparin seven (29%) developed calf vein thrombosis as detected by the radioactive fibrinogen technique. None of the 24 heparinized patients had any evidence of venous thrombosis. This difference is significant at the 1% level.